SEC Tracker
Get the app
CRL · XBRL financial data

Charles River Laboratories International financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (CRL's year ends in late December)

In millions of dollarsDec 30, 2023Mar 30, 2024Jun 29, 2024Sep 28, 2024Dec 28, 2024Mar 29, 2025Jun 28, 2025Sep 27, 2025Dec 27, 2025Mar 28, 2026Jun 27, 2026Sep 26, 2026
Revenue from contracts with customers1,013*1,0121,0261,0101,003*9841,0321,005994*9961,004983
Cost of goods and services sold—667672661————————
Selling, general and administrative197*186170199196*178192178196*159229141
Operating income (loss)133*126152117(168)*75100134(283)*120120203
Interest income2*2322*1111*111
Interest expense34*35333028*28302524*273029
Other income (expense)108*6(2)3(23)*(12)0(23)12*(124)(37)(4)
Income tax expense (benefit)20*252521(3)*101932(18)*(15)54(164)
Net income (loss)187*739470(214)*255254(277)*(15)(1)333
Earnings per share, basic USD per share3.65*1.311.751.34(4.19)*0.501.061.11(5.62)*(0.30)(0.03)6.97
Earnings per share, diluted USD per share3.65*1.301.741.33(4.19)*0.501.061.10(5.68)*(0.30)(0.03)6.86
Weighted average shares, basic millions of shares51*51525151*51494949*494848
Weighted average shares, diluted millions of shares51*52525251*51494949*494849

Balance sheet

CSV

Fiscal quarters (CRL's year ends in late December)

In millions of dollarsDec 30, 2023Mar 30, 2024Jun 29, 2024Sep 28, 2024Dec 28, 2024Mar 29, 2025Jun 28, 2025Sep 27, 2025Dec 27, 2025Mar 28, 2026Jun 27, 2026Sep 26, 2026
Cash and cash equivalents277327179210195229183207214192192200
Accounts receivable780787762754721757768734709700712735
Inventory380361349336279290280303299360346320
Prepaid and other current assets8399111102106100130166129135179182
Total current assets1,6091,6681,4991,4951,4031,5061,4701,5321,4471,4891,5291,535
Property and equipment, net1,640———1,6041,5871,6071,5921,6551,5101,4951,497
Right-of-use asset394384386385412403386374361318330332
Goodwill3,0953,0703,0803,1252,8472,8732,9362,9222,7643,0403,0773,084
Total assets8,1958,1537,9488,0047,5287,5827,5617,5147,1357,7307,5327,452
Accounts payable169130133136140149146170149134141145
Accrued liabilities228191192208232242232229270372380286
Current portion of long-term debt300000000752
Total current liabilities1,0559559481,0129941,0511,0801,1221,1201,0941,1351,089
Lease liability, non-current419418429433484475454443434393408405
Total liabilities4,5364,4494,1754,1764,0204,3414,1614,0633,9244,7424,6444,176
Retained earnings1,8871,9602,0542,1231,8121,8381,8901,9441,3891,3741,3721,705
Total stockholders' equity3,5973,6403,7233,7823,4623,1943,3533,4053,1652,9412,8403,227
Total liabilities and equity8,1958,1537,9488,0047,5287,5827,5617,5147,1357,7307,5327,452
Common shares outstanding (cover page) millions of shares515252515149494949484848

Cash flows

CSV

Fiscal quarters (CRL's year ends in late December)

In millions of dollarsDec 30, 2023Mar 30, 2024Jun 29, 2024Sep 28, 2024Dec 28, 2024Mar 29, 2025Jun 28, 2025Sep 27, 2025Dec 27, 2025Mar 28, 2026Jun 27, 2026Sep 26, 2026
Net income (loss)187*739470(214)*255254(277)*(15)(1)333
Stock-based compensation20*1717*19*17*1317*23*18*2220*21*
Depreciation and amortization81*858688102*1201208578*676772
Net cash from operating activities221*130194*252*159*172205*214*148*41180*254*
Net cash from investing activities(238)*(86)(62)*(21)*(76)*(45)(37)*(34)*(93)*(408)28*10*
Share repurchases0*99*101*0*3537*0*0*208116*0*
Proceeds from long-term debt443*301440*236*105*416547*107*157*912353*155*
Net cash from financing activities124*18(286)*(208)*(76)*(105)(227)*(153)*(52)*348(165)*(254)*
Net change in cash119*54(158)*31*(6)*26(47)*24*7*(18)42*9*

Compare with peers

SIC 8731 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 8731 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingQuarter
Charles River Laboratories International200983254*47.9M 10-QSep 26, 2026
Medpace Holdings705716217*28.0M 10-QSep 30, 2026
Incyte3,2761,557(675)*203.8M 10-QSep 30, 2026
UL Solutions1,016823215*not reported 10-QSep 30, 2026
Iqvia Holdings2,2494,428825*164.8M 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.

Data on this page was fetched . The filing on SEC.gov is the record.